Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

By M. Rutter, B. Saunders, K. Wilkinson, S. Rumbles, G. Schofield, M. Kamm, C. Williams, A. Price, I. Talbot, A. Forbes. Gastroenterology, 2004

1,283 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function (2010, background): “Patients with ulcerative colitis and Crohn's disease are at increased risk of developing colon cancer and this risk is proportional to the degree of inflammatio”
Infliximab for induction and maintenance therapy for ulcerative colitis. (2005, neutral): “[27,28]”
Effect of 5-Aminosalicylate Use on Colorectal Cancer and Dysplasia Risk: A Systematic Review and Metaanalysis of Observational Studies (2005, background): “In almost all studies, 5-ASA use was assessed through medical record review (11–15, 17, 19) and patient contact (13, 17, 19).”
Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. (2004, background): “However, when colitis activity has been defined histologically, a recent case-control study found that greater degrees of histologically active inflammation were indeed associated with increased risk of CRC (74).”